TNFSF10 and Miyoshi myopathy: In conclusion, our data show that α-TOS efficiently potentiates TRAIL killing of MM cells that are highly resistant to established treatment via mitochondrial mechanisms, and prompt testing of TRAIL and α-TOS, as well as other vitamin E analogues (Birringer et al, 2003), in preclinical models of MM.